Dave Sheppard and Florence Joffroy-Black, MedWorld Advisors

MedWorld Advisors' CEO Florence Joffroy-Black is a long-time medtech M&A and marketing expert. She can be reached at florencejblack@medworldadvisors.com. Managing Director Dave Sheppard is a former medical OEM Fortune 500 executive and an experienced medtech M&A professional. He can be reached at davesheppard@medworldadvisors.com. Value = Strategic Fit + Timing® is a registered trademark of MedWorld Advisors.

Medtech M&A 2025 – What’s happening?

It will be exciting to watch this M&A resurgence continue to take shape through 2025 and beyond.

Is AI still the medtech trend to look toward in 2025?

These are just a few of the AI trends we forecast for 2025. We’re energized and excited to see how improvements and innovations in AI will continue to improve healthcare.

Medtech M&A leads the way into 2025!

From our perspective in working with private equity (PE) and strategic companies in 2024, mergers and acquisitions (M&A) continues to be highly active in medtech.

Possible benefits of upcoming Fed rate cuts for medical industry manufacturers

The anticipated reductions in U.S. federal interest rates present opportunities for medical industry manufacturers and may also benefit those owners among us that are looking to sell. The good news for us in the M&A segment of our industry is 2024 is already turning into a record year with excellent valuations.

Should you do it alone?

Selling your business is a significant decision. As a business owner, chances are this question is often on your mind simply because of the number of phone calls you receive on a regular basis from would-be buyers.

Knowing what you want out of a deal is a key to a successful exit

Every seller has a different need and every buyer has their own motives. Below, find a few examples showcasing such difference in transactions; giving you something to think about if you’re thinking of selling.

Is being an OEM supplier part of your strategy?

Being an OEM supplier can provide your company with growth and stability; it can be a win-win for both you and your customer and open the door to new opportunities.

Thinking of selling; the numbers are on your side!

If you have good numbers, you’ll get the attention of the PE firms at a good valuation. And, if you happen to catch the attention of a strategic, your numbers may get even a bit better!

Key impacts to consider for 2024?

Elections and the healthcare hot potato; Increase in M&A due to the dry powder and strategic valuations; Robotics and enabling technologies continuing to gain adoption; AI / ML continues to evolve